Schedule 13G ownership disclosure
Integra LifeSciences Holdings Corp
Security class unavailable · CUSIP: 457985208
Event date: 2023-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,435,957
- Percent of class
- 3.1200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001315478-24-000018
- Form type
- SC 13G
- Filer
- Champlain Investment Partners, LLC
- CIK
- CIK 1315478
- Filed
- Feb 13, 2024
- Reporting period
- Dec 31, 2023
- Description
- Schedule 13G beneficial ownership